Insider Transactions in Q1 2021 at Ayala Pharmaceuticals, Inc. (AYLA)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 24
2021
|
Gary B. Gordon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,000
-26.04%
|
$51,000
$17.46 P/Share
|
|
Feb 24
2021
|
Gary B. Gordon Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+20.66%
|
$15,000
$5.16 P/Share
|
|
Feb 24
2021
|
Roni Mamluk President & CEO |
SELL
Open market or private sale
|
Direct |
10,800
-6.92%
|
$183,600
$17.4 P/Share
|
|
Feb 23
2021
|
Roni Mamluk President & CEO |
SELL
Open market or private sale
|
Direct |
7,126
-4.36%
|
$121,142
$17.89 P/Share
|
|
Feb 22
2021
|
Roni Mamluk President & CEO |
SELL
Open market or private sale
|
Direct |
15,200
-8.52%
|
$288,800
$19.86 P/Share
|
|
Jan 21
2021
|
Roni Mamluk President & CEO |
SELL
Open market or private sale
|
Direct |
1,406
-0.78%
|
$21,090
$15.04 P/Share
|
|
Jan 20
2021
|
Gary B. Gordon Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,000
-26.04%
|
$45,000
$15.03 P/Share
|
|
Jan 20
2021
|
Gary B. Gordon Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+20.66%
|
$15,000
$5.16 P/Share
|
|
Jan 20
2021
|
Roni Mamluk President & CEO |
SELL
Open market or private sale
|
Direct |
19,466
-9.77%
|
$291,990
$15.03 P/Share
|
|
Jan 04
2021
|
Roni Mamluk President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
34,080
+14.6%
|
-
|
|
Jan 04
2021
|
Yossi Maimon CFO, Secretary and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
8,520
+30.01%
|
-
|
|
Jan 04
2021
|
Gary B. Gordon Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,520
+50.0%
|
-
|